Suzhou Municipal Key Lab for Metabolic Syndrome Drug Research

Suzhou Municipal Key Lab for Metabolic Syndrome Drug Research

Overview

Suzhou Key Laboratory for Metabolic Syndrome New Drug Research was established in 2010. It is the first of its kind in the Chinese mainland. With a total investment of more than 40 million RMB, it is committed to exploring the molecular mechanisms of disease, system and structural biology, protein and bioengineering, cell communication and new drug research at the molecular and cellular level.

The laboratory encourages industry-university-research cooperation and interdepartmental collaboration. It contributes to scientific research instruments, and supports disciplinary research in corresponding fields.

Research areas

  • Molecular mechanism of Metabolic Syndrome
  • Therapeutic, diagnostic, and advanced material innovations for metabolic syndrome-related diseases
  • Microbiota and Metabolic Diseases

Mission& objectives

To advance research in metabolic syndrome and drug development through industry-academia-research collaboration, talent development, and international partnerships. The lab focuses on building a provincial key research platform, ensuring expected outcomes, and securing funding to solidify its position as a world-class research institution with impactful results in the field.

To secure increased funding, publish high-quality research papers, establish partnerships with industry and academic institutions, host metabolism-related events, achieve recognition as a Provincial Key Lab, and develop a mentorship program for students. The overall goal is to become a leading force in metabolic research.

Contact us